Asunto(s)
Tumores Neuroendocrinos , Neoplasias Pancreáticas , Bazo , Humanos , Tumores Neuroendocrinos/diagnóstico por imagen , Tumores Neuroendocrinos/patología , Diagnóstico Diferencial , Neoplasias Pancreáticas/diagnóstico por imagen , Neoplasias Pancreáticas/patología , Bazo/diagnóstico por imagen , Masculino , Tomografía Computarizada por Tomografía de Emisión de Positrones , Femenino , Persona de Mediana Edad , Coristoma/diagnóstico por imagenAsunto(s)
Betacoronavirus , Infecciones por Coronavirus/diagnóstico por imagen , Melanoma/diagnóstico por imagen , Neumonía Viral/diagnóstico por imagen , Tomografía Computarizada por Tomografía de Emisión de Positrones , Neoplasias Cutáneas/diagnóstico por imagen , Anciano , COVID-19 , Resultado Fatal , Femenino , Fluorodesoxiglucosa F18 , Humanos , Pierna/diagnóstico por imagen , Pulmón/diagnóstico por imagen , Melanoma/patología , Pandemias , Radiofármacos , SARS-CoV-2 , Neoplasias Cutáneas/patologíaRESUMEN
UNLABELLED: The sentinel lymph node (SLN) biopsy is currently the procedure of choice for axillary node staging in initial stages of breast cancer. The purpose of this study is to establish our false negative rate within a 5-year follow-up period in 258 patients with breast cancer staged with this procedure. METHODS: A retrospective study on 258 consecutive T1-T2<3 cm pN0 staged breast carcinomas treated from January 1, 2001 to December 31, 2005 was performed. The combined technique of isotope plus blue dye was used for detection. The subjects underwent a minimum follow-up of 5 years, mean 81 months, with an end of follow-up at December 31, 2010. Evidence of axillary recurrence, tumor recurrence in the breast and signs of disease progression or death were the events collected and analyzed. RESULTS: Of the 258 patients, 3 false negatives (1.1%) with axillary recurrence were detected at 10, 11 and 29 months of the surgery. This did not have a significant repercussion in the survival analysis on the contrary to the existence of breast recurrence or the appearance of distant metastasis in 4.7% and 6.2% patients, respectively. Global survival related with the cancer was 93.0 (240/258) and disease free survival was 89.1% (230/258). CONCLUSION: The risk of developing axillary recurrence after a negative SLN without axillary node dissection is low enough to consider the SLN procedure to be the best approach for axilla staging in early breast cancer. This staging technique also makes it possible to achieve local disease control without diminishing the survival of the patients.
Asunto(s)
Neoplasias de la Mama/patología , Carcinoma Ductal de Mama/secundario , Metástasis Linfática , Biopsia del Ganglio Linfático Centinela/estadística & datos numéricos , Adulto , Anciano , Anciano de 80 o más Años , Axila , Neoplasias de la Mama/cirugía , Neoplasias de la Mama/terapia , Carcinoma Ductal de Mama/diagnóstico , Carcinoma Ductal de Mama/epidemiología , Carcinoma Ductal de Mama/cirugía , Carcinoma Lobular/diagnóstico , Carcinoma Lobular/epidemiología , Carcinoma Lobular/secundario , Carcinoma Lobular/cirugía , Quimioterapia Adyuvante , Terapia Combinada , Supervivencia sin Enfermedad , Estrógenos , Reacciones Falso Negativas , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Escisión del Ganglio Linfático , Metástasis Linfática/diagnóstico por imagen , Mastectomía/métodos , Persona de Mediana Edad , Estadificación de Neoplasias , Neoplasias Hormono-Dependientes/diagnóstico , Neoplasias Hormono-Dependientes/epidemiología , Neoplasias Hormono-Dependientes/secundario , Neoplasias Hormono-Dependientes/cirugía , Progesterona , Pronóstico , Cintigrafía , Radioterapia Adyuvante , Estudios Retrospectivos , Colorantes de Rosanilina , Biopsia del Ganglio Linfático Centinela/métodos , Análisis de Supervivencia , Azufre Coloidal Tecnecio Tc 99mRESUMEN
AIM: To determine the clinical utility of the gated myocardial perfusion SPECT to detect silent ischemia in asymptomatic diabetic patients without previous coronary events and to evaluate the prognosis of this population. MATERIAL AND METHODS: A retrospective study of 56 asymptomatic diabetics referred for a gated myocardial perfusion SPECT for diagnosis of ischemic disease was performed. The criteria for ischemia were: mild SDS<4, moderate SDS 4-8, severe SDS>8. A multivariable statistical analysis was carried out to identify possible predictive variables of an abnormal SPECT. The cardiovascular events were recorded up to December-2010. RESULTS: A high proportion of the 56 patients had an abnormal perfusion study (46.4%), there being moderate-severe ischemia in 10.7%, necrosis with ischemia in 5.4% and necrosis in 7.1%. We found no statistical differences in the type of stress used (treadmill or dipyridamole). The patients had a high combination of cardiovascular risk factors. In the multivariate analysis, diabetic nephropathy was the only factor related to an abnormal SPECT (p=0.043). The events recorded in the follow-up were: 2 early revascularizations, 5 cardiology admissions, 10 non-cardiac related deaths. The existence of ischemia in the SPECT was significantly related to the appearance of cardiovascular events (p<0.05). CONCLUSION: A gated myocardial perfusion SPECT in asymptomatic diabetics with high combination of cardiovascular risk factors detects silent ischemia in a significant proportion and this seems to be related to future coronary events. Diabetic nephropathy implies a greater likelihood of abnormal studies. However, the screening criteria in this population still need to be established for better performance and lower cost.